Yuji Kazuta

460 citations

19 papers · 396 indexed · h-index 12

Co-authors: Akira Matsuda Satoshi Shuto Hiroshi Abe Shizuo Yamada Kazuya Yamaguchi Kazufumi Hirano Tamotsu Yamamoto Hideki Hayashi
Topics: Cyclopropane Reaction Mechanisms (8 papers)Asymmetric Synthesis and Catalysis (7 papers)Synthetic Organic Chemistry Methods (5 papers)
Cited by: Organic Chemistry Pharmaceutical Science Molecular Biology
Journals: The Journal of Physical Chemistry B FEBS Letters Journal of Medicinal Chemistry
Partner nations: Japan United States

In The Last Decade

Yuji Kazuta

18 papers receiving 393 citations

Peers

Countries citing papers authored by Yuji Kazuta

Since Specialization

Citations

This map shows the geographic impact of Yuji Kazuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Kazuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Kazuta more than expected).

Fields of papers citing papers by Yuji Kazuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Kazuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Kazuta. The network helps show where Yuji Kazuta may publish in the future.

Co-authorship network of co-authors of Yuji Kazuta

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Kazuta. A scholar is included among the top collaborators of Yuji Kazuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Kazuta. Yuji Kazuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Discovery ofE2730, a novel selective uncompetitiveGAT1inhibitor, as a candidate for anti‐seizure medication 2023 ·Epilepsia Open ·Kazuyuki Fukushima,Hiroyuki Higashiyama,Yuji Kazuta,Keisuke Hashimoto,Naoto Watanabe,Yoshiaki Furuya,Yoshimasa Ito,(unknown),Takashi Kosasa,Delia M. Talos,(unknown),(unknown),Frances E. Jensen,Takahisa Hanada,Katsutoshi Ido	5
2	Silinanyl Rhodamines and Silinanyl Fluoresceins for Super-Resolution Microscopy 2021 ·The Journal of Physical Chemistry B ·(unknown),Shin‐nosuke Uno,(unknown),Yuji Kazuta,(unknown),(unknown),(unknown),Yuki Shimaoka,(unknown),Masaya Okada,Youichi Nishikawa,(unknown),Shigeki Iwanaga	14
3	An orange-fluorescent dye with long-lasting blinking for single molecule localization microscopy 2020 ·(unknown),(unknown),(unknown),Youichi Nishikawa,(unknown),Yuji Kazuta,(unknown),(unknown),Shigeki Iwanaga	0
4	Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists 2014 ·Bioorganic & Medicinal Chemistry ·Yu Yoshida,(unknown),(unknown),Yuji Kazuta,(unknown),Carsten T. Beuckmann,Makoto Nakagawa,Michiyuki Suzuki,Ikuo Kushida,Osamu Takenaka,Takashi Ueno,Masahiro Yonaga	20
5	Synthesis of 1-arylpiperazyl-2-phenylcyclopropanes designed as antidopaminergic agents: Cyclopropane-based conformationally restricted analogs of haloperidol 2008 ·Bioorganic & Medicinal Chemistry ·Kazuya Yamaguchi,Yuji Kazuta,Kazufumi Hirano,Shizuo Yamada,Akira Matsuda,Satoshi Shuto	17
6	Stereochemical Diversity-Oriented Conformational Restriction Strategy. Development of Potent Histamine H ₃ and/or H ₄ Receptor Antagonists with an Imidazolylcyclopropane Structure 2006 ·Journal of Medicinal Chemistry ·Mizuki Watanabe,Yuji Kazuta,Hideki Hayashi,Shizuo Yamada,Akira Matsuda,Satoshi Shuto	52
7	P-253 DEVELOPMENT OF POTENT HISTAMINE H_3 AND/OR H_4 RECEPTOR ANTAGONISTS BY THE STEREOCHEMICAL DIVERSITY-ORIENTED CONFORMATIONAL RESTRICTION STRATEGY 2006 ·Mizuki Watanabe,Yuji Kazuta,Hideki Hayashi,Shizuo Yamada,Akira Matsuda,Satoshi Shuto	1
8	Highly Stereoselective Grignard Addition to Cis-Substituted C-Cyclopropylaldonitrones. The Bisected s-Trans Transition State Can Be Stabilized Effectively by the Lewis Acid-Coordination 2004 ·The Journal of Organic Chemistry ·Yuji Kazuta,Hiroshi Abe,Akira Matsuda,Satoshi Shuto	10
9	The unusual 1,4-chelation-controlled nucleophilic addition to aldehydes with high stereoselectivity. A systematic study of stereoselectivity in the addition reaction of carbon nucleophiles to cis-substituted cyclopropanecarbaldehydes 2004 ·Tetrahedron ·Yuji Kazuta,Hiroshi Abe,Tamotsu Yamamoto,Akira Matsuda,Satoshi Shuto	12
10	Cyclopropane-Based Conformational Restriction of Histamine. (1S,2S)-2-(2-Aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a Highly Selective Agonist for the Histamine H₃ Receptor, Having a cis-Cyclopropane Structure 2003 ·Journal of Medicinal Chemistry ·Yuji Kazuta,Kazufumi Hirano,(unknown),Shizuo Yamada,Ryohei Kimura,Shun‐ichiro Matsumoto,Kiyoshi Furuichi,Akira Matsuda,Satoshi Shuto	64
11	A Systematic Study of the Hydride Reduction of Cyclopropyl Ketones with Structurally Simplified Substrates. Highly Stereoselective Reductions ofTrans-Substituted Cyclopropyl Ketones via the Bisecteds-CisConformation 2003 ·The Journal of Organic Chemistry ·Yuji Kazuta,Hiroshi Abe,Tamotsu Yamamoto,Akira Matsuda,Satoshi Shuto	27
12	Construction of a cis-Cyclopropane via Reductive Radical Decarboxylation. Enantioselective Synthesis of cis- and trans-1-Arylpiperazyl-2-phenylcyclopropanes Designed as Antidopaminergic Agents 2003 ·The Journal of Organic Chemistry ·Kazuya Yamaguchi,Yuji Kazuta,Hiroshi Abe,Akira Matsuda,Satoshi Shuto	39
13	Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity 2002 ·Bioorganic & Medicinal Chemistry ·Yuji Kazuta,Ryuichi Tsujita,(unknown),Shigeo Uchino,Shinichi Kohsaka,Akira Matsuda,Satoshi Shuto	18
14	Synthesis of (1S,2R)-1-phenyl-2-[(S)-1-aminoalkyl]-N,N-diethylcyclopropanecarboxamides as novel NMDA receptor antagonists having a unique NMDA receptor subtype selectivity 2002 ·Journal of the Chemical Society Perkin Transactions 1 ·Yuji Kazuta,Ryuichi Tsujita,Shigeo Uchino,(unknown),Daisuke Mochizuki,(unknown),(unknown),(unknown),Tamotsu Yamamoto,(unknown),Akira Matsuda,Satoshi Shuto	6
15	Conformational Analysis of the NMDA Receptor Antagonist (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) Designed by a Novel Conformational Restriction Method Based on the Structural Feature of Cyclopropane Ring. 2002 ·Chemical and Pharmaceutical Bulletin ·(unknown),Kiyoshi OGAWA,(unknown),Tamotsu Yamamoto,Yuji Kazuta,Akira Matsuda,Satoshi Shuto	13
16	Development of Versatile cis- and trans-Dicarbon-Substituted Chiral Cyclopropane Units: Synthesis of (1S,2R)- and (1R,2R)-2-Aminomethyl-1-(1H-imidazol-4-yl)cyclopropanes and Their Enantiomers as Conformationally Restricted Analogues of Histamine 2002 ·The Journal of Organic Chemistry ·Yuji Kazuta,Akira Matsuda,Satoshi Shuto	74
17	Establishment of CHO cell lines expressing four N‐methyl‐D‐aspartate receptor subtypes and characterization of a novel antagonist PPDC 2001 ·FEBS Letters ·Shigeo Uchino,Wakako Watanabe,Takeshi Nakamura,Satoshi Shuto,Yuji Kazuta,Akira Matsuda,Sadayo Nakajima‐Iijima,Yoshihisa Kudo,Shinichi Kohsaka,Masayoshi Mishina	8
18	The bisected s-trans conformation-controlled highly stereoselective addition of Grignard reagents to C-cyclopropylaldonitrone. An efficient synthesis of 1-phenyl-2-[(S )-1-aminoalkyl]-N,N-diethylcyclopropanecarboxamides, a new class of potent NMDA receptor antagonists 2001 ·Journal of the Chemical Society Perkin Transactions 1 ·Yuji Kazuta,Satoshi Shuto,Hiroshi Abe,Akira Matsuda	4
19	Highly stereoselective addition of Grignard reagents to C-cyclopropylnitrone via the bisected s-trans conformation. An efficient synthesis of PEDC, a potent NMDA receptor antagonist having a cyclopropane structure 2000 ·Tetrahedron Letters ·Yuji Kazuta,Satoshi Shuto,Akira Matsuda	12

About Yuji Kazuta

Yuji Kazuta is a scholar working on Structural Biology, Organic Chemistry and Biophysics, having authored 19 papers that have together received 396 indexed citations. Recurring topics across this work include Cyclopropane Reaction Mechanisms (8 papers), Asymmetric Synthesis and Catalysis (7 papers) and Synthetic Organic Chemistry Methods (5 papers). The work is most often cited by research in Organic Chemistry (276 citations), Pharmaceutical Science (22 citations) and Molecular Biology (163 citations). Yuji Kazuta has collaborated with scholars based in Japan and United States. Frequent co-authors include Akira Matsuda, Satoshi Shuto, Hiroshi Abe, Shizuo Yamada, Kazuya Yamaguchi, Kazufumi Hirano, Tamotsu Yamamoto, Hideki Hayashi, Mizuki Watanabe and Ryohei Kimura. Their work appears in journals such as The Journal of Physical Chemistry B, FEBS Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact